Renova Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
701 Palomar Airport Rd Ste 300, Carlsbad...Phone Number
(858) 461-1837Website
www.renovatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Renova Therapeutics
Renova Therapeutics is dedicated to creating transformational gene therapies aimed at treating prevalent chronic diseases such as congestive heart failure and type 2 diabetes. The company leverages nearly 50 years of combined expertise in gene therapy to develop innovative treatments that may provide durable, life-long solutions through a single dose. Their investigational therapies are based on validated insights into disease mechanisms, supported by extensive peer-reviewed research. Intended clients include patients suffering from chronic conditions, healthcare professionals, and the pharmaceutical industry.Explore more
Renova Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renova Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Renova Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Renova Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Renova Therapeutics recently announced quarterly report
Check out if Renova Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Renova Therapeutics has new funding data
Renova Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Renova Therapeutics had a recent Job posting/layoffs
Check if Renova Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Renova Therapeutics
Find 2 more new buyers
Compare Similar Companies to Renova Therapeutics
Compare insights from companies similar to Renova Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Renova Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Renova Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Renova Therapeutics.
Renova Therapeutics financials insights
Gather financial insights about Renova Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series C
$7.5M
Renova Therapeutics Tech Stack
A closer look at the technologies used by Renova Therapeutics
Renova Therapeutics News & Media
Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes
SAN DIEGO, June 24, 2018 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that an abstract of a study in a preclinical model of type 1 diabetes was accepted as a...Renova Therapeutics: JACC: Basic to Translational Science publishes article comparing effects of urocortin 2 versus urocortin 3 gene transfer on left ventricular function and glucose disposal
SAN DIEGO, May 4, 2018 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, today announced its cofounder's publication of an article in JACC: Basic to Translational Science 2018;3:2...Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at Keystone Symposium
SAN DIEGO, Jan. 11, 2018 /PRNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that it will present an overview of its RT-100 AC6 gene transfer Phase 3 clinical trial in a...Genetic Rx panel on gene therapy regulatory strategies led by Renova Therapeutics CEO and Co-founder
SAN DIEGO, Dec. 5, 2017 /PRNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the company's CEO and Co-founder, Jack W. Reich, Ph.D., will moderate a gene therapy panel at...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Renova Therapeutics
Sign Up For FreeTo access detailed company insights
Renova Therapeutics is dedicated to creating transformational gene therapies aimed at treating prevalent chronic diseases such as congestive heart failure and type 2 diabetes. The company leverages nearly 50 years of combined expertise in gene therapy to develop innovative treatments that may provide durable, life-long solutions through a single do... Read More
